Skip to main content
Premium Trial:

Request an Annual Quote

Life Tech Begins Clinical Trials of CE Sequencer for HLA Typing; Plans 510(k) Clearance

Premium

Life Technologies has begun clinical trials to prove the safety and effectiveness of sequence-based typing on its 3500 Dx Genetic Analyzer for analyzing the Human Leukocyte Antigen region and plans to apply for 510(k) clearance of the SBT platform, the company said this week.

An undisclosed clinical research organization will oversee the clinical trials at several independent, accredited HLA typing laboratories in the US. These labs will use the 3500 Dx Genetic Analyzer, SeCore kits, and uType Dx software to analyze six gene regions of the HLA system.

"Our intention is to complete clinical trials and pursue 501(k) clearance of the 3500 Dx system and SeCore kits to demonstrate the utility of capillary electrophoresis and sequence-based assays as powerful tools in the molecular diagnostic laboratory," said Todd Laird, vice president and general manager of Life Technologies' Fragment and Sequence Genomics division.

The company expects the clinical trials to be completed this summer, and to seek 510(k) clearance with the US Food and Drug Administration after that.

Life Tech launched the 3500 Genetic Analyzer two years ago, with a Dx version initially offered only in the European Union and, later, other countries (IS 7/13/2010). The instrument comes with either eight or 24 capillaries.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.